Pharmacologic management of obesity

Robert F. Kushner*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

5 Scopus citations


Recent discoveries of processes that govern regulation of body weight and energy expenditure have led to development of new anti-obesity pharmacological agents. This article will inform health professionals of new anti-obesity medications that target neuronal systems within the central nervous system (CNS) and peripheral humoral proteins that send signals to the CNS. An emerging theme of new therapies is to use combination medications that are directed toward several targets or leverage existing gastrointestinal satiety hormonal signals. By using combination therapies, it is anticipated that greater weight loss will be achieved compared to monotherapy.

Original languageEnglish (US)
Pages (from-to)140-143
Number of pages4
JournalPediatric Blood and Cancer
Issue number1
StatePublished - Jan 2012


  • Appetite regulation
  • Gut peptides
  • Obesity
  • Pharmacotherapy
  • Weight loss

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology


Dive into the research topics of 'Pharmacologic management of obesity'. Together they form a unique fingerprint.

Cite this